Results 241 to 250 of about 4,968,206 (256)

Clinical Evaluation of Siponimod for the Treatment of Secondary Progressive Multiple Sclerosis: Pathophysiology, Efficacy, Safety, Patient Acceptability and Adherence

Patient Preference and Adherence, 2022
Mary Rensel, Georges Jalkh, Gabrielle Macaron   +2 more
exaly  

Elevated sCD40L in Secondary Progressive Multiple Sclerosis in Comparison to Non-progressive Benign and Relapsing Remitting Multiple Sclerosis

Journal of Central Nervous System Disease, 2021
Yang Mao-Draayer, Jennifer Yang, Qin Wang   +2 more
exaly  

Defining secondary progressive multiple sclerosis.

Brain, 2016
Raed Alroughani, Thor Petersen, Alexandre Prat   +2 more
exaly  

Diagnostic uncertainty during the transition to secondary progressive multiple sclerosis

Multiple Sclerosis Journal, 2014
Ilana Katz Sand, Stephen Krieger, Colleen Farrell   +2 more
exaly  

The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis.

Brain, 2000
Gareth J. Barker, Massimo Filippi, Tarek A Yousry   +2 more
exaly  

Decreasing impact of late relapses on disability worsening in secondary progressive multiple sclerosis

Multiple Sclerosis Journal, 2020
Emmanuelle Leray, Kévin Ahrweiller, Anne Kerbrat   +2 more
exaly  

Lower levels of glutathione in the brains of secondary progressive multiple sclerosis patients measured by 1H magnetic resonance chemical shift imaging at 3 T.

Multiple Sclerosis Journal, 2011
In-Young Choi, S G Lynch
exaly  

The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis

Multiple Sclerosis Journal, 2017
Jeffrey A Cohen, Hans-Peter Hartung, Diego Cadavid   +2 more
exaly  

Diagnosis and Management of Secondary-Progressive Multiple Sclerosis: Time for Change

Neurodegenerative Disease Management, 2019
Jiwon Oh, Paul S Giacomini, Robyn Schecter   +2 more
exaly  

Placebo-controlled multicentre randomised trial of interferon β-1b in treatment of secondary progressive multiple sclerosis

Lancet, The, 1998
Ludwig Kappos
exaly